Reviva Pharmaceuticals Holdings, Inc. Income (Loss) from Continuing Operations before Income Taxes, Domestic
Reviva Pharmaceuticals Holdings, Inc. (RVPH) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$19.93 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-30
- Reviva Pharmaceuticals Holdings, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$19.93M.
- Reviva Pharmaceuticals Holdings, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$29.85M.
- Reviva Pharmaceuticals Holdings, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$39.30M.
- Reviva Pharmaceuticals Holdings, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$28.28M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$19.93M 10-K · filed 2026-03-30 | |
| 2024-12-31 | -$29.85M 10-K · filed 2026-03-30 | |
| 2023-12-31 | -$39.30M 10-K · filed 2025-04-03 | |
| 2022-12-31 | -$28.28M 10-K · filed 2024-04-15 | -$24.36M 10-K · filed 2023-03-30 |
| 2021-12-31 | -$8.54M 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |